-36:

Shuting Tan1, Yongheng Li2, Zhenshuai Yao3

  • 1Aging Health Research Center, School of Nursing, Health Science Center, Hunan Normal University, Changsha, 410013, China; The Fourth Hospital of Changsha (Integrated Traditional Chinese and Western Medicine Hospital of Changsha), Changsha, 410006, China.

PubMed
概括

介素-36 (IL-36) 通过促进血管炎症和破坏胆固醇代谢来驱动动动脉硬化. 向IL-36提供了一种有希望的策略,以减少除了他类药物治疗之外的残留心血管疾病风险.